NYSE · CIK 0000001750
AIR AAR CORP
Insider trading from SEC Form 4. Last filing Mar 31, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at AAR CORP, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 55Moderate | sell 5 | Holmes John McClain III Chairman, President & CEO | $354k | 5,000 | -1% | - | |
| 50Moderate | sell 5 | Jessup Christopher A. Senior Vice President-CCO | $2.4M | 33,981 | -48% | - | |
| 60Notable | sell 5 | Holmes John McClain III Chairman, President & CEO | $8.6M | 128,427 | -34% | - | |
| 40Moderate | sell 5 | Garascia Jessica A. Senior VP, GC, CAO & Secretary | $100k | 1,500 | -4% | - | |
| 52Moderate | sell 5 | Pachapa Eric VP-CAO & Controller | $435k | 6,500 | -21% | - | |
| 52Moderate | sell 5 | Gillen Sean M. Senior VP-CFO | $1.2M | 17,385 | -22% | - |
Transactions
The last 45 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Widhani Hema director | AGrant or award Phantom Stockderivative | +391 | $0.00 | $0 | 391 | Mar 31, 2025 |
| Mar 25, 2025 | Pachapa Eric VP-CAO & Controller | FTax withholding Common Stock | -1,623 | $69.62 | $113k | 22,719 | Mar 26, 2025 |
| Mar 25, 2025 | Jessup Christopher A. Senior Vice President-CCO | FTax withholding Common Stock | -4,326 | $69.62 | $301k | 58,883 | Mar 26, 2025 |
| Mar 25, 2025 | Holmes John McClain III Chairman, President & CEO | FTax withholding Common Stock | -63,866 | $69.62 | $4.4M | 274,814 | Mar 26, 2025 |
| Feb 28, 2025 | LEDUC ROBERT F director | AGrant or award Phantom Stockderivative | +219 | $65.02 | $14k | 4,500 | Mar 3, 2025 |
| Feb 28, 2025 | WALFISH MARC JAY director | AGrant or award Phantom Stockderivative | +558 | $65.02 | $36k | 51,937 | Mar 3, 2025 |
| Jan 22, 2025 | Holmes John McClain III Chairman, President & CEO | GGift Common Stock | -3,000 | $0.00 | $0 | 338,680 | Jan 22, 2025 |
| Jan 17, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -5,000 | $70.81 | $354k | 341,680 | Jan 21, 2025 |
| Jan 15, 2025 | Jessup Christopher A. Senior Vice President-CCO | MOption exercise Common Stock | +500 | $18.94 | $9,470 | 70,797 | Jan 17, 2025 |
| Jan 15, 2025 | Jessup Christopher A. Senior Vice President-CCO | SOpen-market sale Common Stock | -500 | $70.19 | $35k | 70,297 | Jan 17, 2025 |
| Jan 16, 2025 | Jessup Christopher A. Senior Vice President-CCO | MOption exercise Common Stock | +26,393 | $18.94 | $500k | 96,690 | Jan 17, 2025 |
| Jan 16, 2025 | Jessup Christopher A. Senior Vice President-CCO | SOpen-market sale Common Stock | -26,393 | $70.42 | $1.9M | 70,297 | Jan 17, 2025 |
| Jan 16, 2025 | Jessup Christopher A. Senior Vice President-CCO | SOpen-market sale Common Stock | -7,088 | $70.35 | $499k | 63,209 | Jan 17, 2025 |
| Jan 15, 2025 | Jessup Christopher A. Senior Vice President-CCO | MOption exercise Stock Optionderivative | -500 | $0.00 | $0 | 26,393 | Jan 17, 2025 |
| Jan 16, 2025 | Jessup Christopher A. Senior Vice President-CCO | MOption exercise Stock Optionderivative | -26,393 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Common Stock | +12,307 | $35.26 | $434k | 378,987 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -12,307 | $66.83 | $822k | 366,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Common Stock | +496 | $35.26 | $17k | 367,176 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -496 | $67.40 | $33k | 366,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Common Stock | +48,000 | $37.66 | $1.8M | 414,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -48,000 | $67.40 | $3.2M | 366,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Common Stock | +32,957 | $18.94 | $624k | 399,637 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -32,957 | $66.46 | $2.2M | 366,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Common Stock | +14,667 | $18.94 | $278k | 381,347 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -14,667 | $66.05 | $969k | 366,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -11,359 | $66.40 | $754k | 355,321 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | SOpen-market sale Common Stock | -8,641 | $65.84 | $569k | 346,680 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Stock Optionderivative | -12,307 | $0.00 | $0 | 496 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Stock Optionderivative | -496 | $0.00 | $0 | 0 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Stock Optionderivative | -48,000 | $0.00 | $0 | 78,225 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Stock Optionderivative | -32,957 | $0.00 | $0 | 14,667 | Jan 13, 2025 |
| Jan 10, 2025 | Holmes John McClain III Chairman, President & CEO | MOption exercise Stock Optionderivative | -14,667 | $0.00 | $0 | 0 | Jan 13, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | MOption exercise Common Stock | +5,385 | $37.66 | $203k | 77,711 | Jan 10, 2025 |
| Jan 10, 2025 | Pachapa Eric VP-CAO & Controller | SOpen-market sale Common Stock | -6,500 | $66.93 | $435k | 24,342 | Jan 10, 2025 |
| Jan 10, 2025 | Garascia Jessica A. Senior VP, GC, CAO & Secretary | SOpen-market sale Common Stock | -1,500 | $66.90 | $100k | 37,565 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | SOpen-market sale Common Stock | -5,385 | $66.33 | $357k | 72,326 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | MOption exercise Common Stock | +8,000 | $18.94 | $152k | 80,326 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | SOpen-market sale Common Stock | -8,000 | $66.33 | $531k | 72,326 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | MOption exercise Common Stock | +4,000 | $37.74 | $151k | 76,326 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | SOpen-market sale Common Stock | -4,000 | $66.33 | $265k | 72,326 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | MOption exercise Stock Optionderivative | -5,385 | $0.00 | $0 | 0 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | MOption exercise Stock Optionderivative | -8,000 | $0.00 | $0 | 47,870 | Jan 10, 2025 |
| Jan 10, 2025 | Gillen Sean M. Senior VP-CFO | MOption exercise Stock Optionderivative | -4,000 | $0.00 | $0 | 7,970 | Jan 10, 2025 |
| Nov 29, 2024 | LEDUC ROBERT F director | AGrant or award Phantom Stockderivative | +205 | $69.52 | $14k | 4,281 | Dec 2, 2024 |
| Nov 29, 2024 | WALFISH MARC JAY director | AGrant or award Phantom Stockderivative | +521 | $69.52 | $36k | 51,379 | Dec 2, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Garascia Jessica A.Senior VP, GC, CAO & Secretary
- Gillen Sean M.Senior VP-CFO
- Holmes John McClain IIIChairman, President & CEO
- Jessup Christopher A.Senior Vice President-CCO
- LEDUC ROBERT Fdirector
- Pachapa EricVP-CAO & Controller
- WALFISH MARC JAYdirector
- Widhani Hemadirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.